Reproductive Health in Women with Major β-Thalassemia: Evaluating Ovarian Reserve and Endocrine Complications
Metabolites · 20.12.2024 · 14 (12) · 717
DOI: 10.3390/metabo14120717 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Metabolites, online erschienen am 20.12.2024. Verfasst von Vasileios Tsilionis und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Faculty of Medicine, School of Health Sciences, University of Thessaly, 41110 Larissa, Greece. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Thalassemia is an autosomal recessive hereditary chronic hemolytic anemia characterized by a partial or complete deficiency in the synthesis of alpha- or beta-globin chains, which are essential components of adult hemoglobin. Mutations in the globin genes lead to the production of unstable globin chains that precipitate within cells, causing hemolysis. This shortens the lifespan of mature red blood cells (RBCs) and results in the premature destruction of RBC precursors in the bone marrow. Regular red blood cell transfusions are the standard treatment for thalassemia. However, these transfusions can lead to increased iron overload, which can impair vital systems such as the liver, heart, ovaries, and endocrine system. Focusing on female reproductive endocrinology, recurrent blood transfusions can cause iron accumulation in the pituitary and hypothalamus, leading to hypogonadotropic hypogonadism (HH), the most common endocrinopathy in these patients, affecting 40–91% of women. Recurrent transfusions and the resulting iron overload can also lead to oxidative stress and ovarian damage in patients with beta-thalassemia major (BTM). Despite advancements in iron chelation therapy, hypothalamic–pituitary damage associated with HH contributes to subfertility and sexual dysfunction, often with little to no recovery. In women exposed to gonadotoxic drugs, particularly those with BTM, anti-Mullerian hormone (AMH)—a marker of ovarian reserve—is frequently used to assess ovarian damage. This review aims to explore the pathophysiology of β-thalassemia and its major clinical manifestations, with a focus on endocrine complications and their impact on ovarian reserve. It also investigates how metabolomics can provide insights into the disease’s metabolic alterations and inform current and emerging therapeutic strategies to mitigate complications and optimize patient outcomes, potentially leading to more effective and personalized treatments.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Faculty of Medicine, School of Health Sciences, University of Thessaly, 41110 Larissa, Greece.
- Laboratory of Medical Genetics, Faculty of Medicine, School of Health Sciences, University of Ioannina, 45110 Ioannina, Greece.
- Department of Health Sciences, European University Cyprus, Nicosia 2404, Cyprus.
- Obstetrics and Gynecology, Royal Devon and Exeter Hospital Barrack Rd., Exeter EX2 5DW, UK.
- Department of Embryology, Faculty of Medicine, School of Health Sciences, University of Thessaly, 41110 Larissa, Greece.
- Department of Urology, School of Medicine, Ioannina University, 45110 Ioannina, Greece.
ORCID-Profile: Efthalia Moustakli, Athanasios Zikopoulos, Konstantinos Dafopoulos
Zitieren
APA
Tsilionis, V., Moustakli, E., Dafopoulos, S., Zikopoulos, A., Sotiriou, S., Zachariou, A., & Dafopoulos, K. (2024). Reproductive Health in Women with Major β-Thalassemia: Evaluating Ovarian Reserve and Endocrine Complications. Metabolites, 14(12), 717. https://doi.org/10.3390/metabo14120717
Vancouver
Tsilionis V, Moustakli E, Dafopoulos S, Zikopoulos A, Sotiriou S, Zachariou A, et al. Reproductive Health in Women with Major β-Thalassemia: Evaluating Ovarian Reserve and Endocrine Complications. Metabolites. 2024;14(12):717. doi:10.3390/metabo14120717
BibTeX
@article{Tsilionis2024,
author = {Tsilionis, Vasileios and Moustakli, Efthalia and Dafopoulos, Stefanos and Zikopoulos, Athanasios and Sotiriou, Sotirios and Zachariou, Athanasios and Dafopoulos, Konstantinos},
title = {Reproductive Health in Women with Major β-Thalassemia: Evaluating Ovarian Reserve and Endocrine Complications},
journal = {Metabolites},
year = {2024},
volume = {14},
number = {12},
pages = {717},
doi = {10.3390/metabo14120717}
}
EUVIMED